David Moatazedi, See Remarks at Evolus, Inc. (EOLS), sold 233,440 shares at $4.89 ($1.1M) on 2026-03-17, disclosed to the SEC on 2026-03-18.
Scheduled sale ($1.1M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.89 | 116,720 | $571K | 50.0% |
| 2 | $4.89 | 116,720 | $571K | 50.0% |
| Total | $4.89 avg | 233,440 | $1.1M | 100% |
| Filing → |
| EOLS | SELL | 2026-03-20 | $130K | — | Filing → |
| EOLS | SELL | 2025-12-29 | $151K | — | Filing → |
| EOLS | SELL | 2025-06-16 | $2.6M | — | Filing → |